Obstructive sleep apnea and depression: A review

Innovations in Clinical Neuroscience

Volumn 8, Issue 8, 2011, Pages 17-25

  Ejaz, Shakir M ^a,b   Khawaja, Imran S ^b,c   Bhatia, Subhash ^d   Hurwitz, Thomas D ^b,c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Continuous positive airway pressure; CPAP; Depression; Obstructive sleep apnea; OSA; Sleep disordered breathing

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; OXYGEN; PAROXETINE; PLACEBO; SEROTONIN;

ANXIETY DISORDER; APNEA HYPOPNEA INDEX; AROUSAL; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; CONCENTRATION LOSS; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATIGUE; HUMAN; HYPERTENSION; HYPOXEMIA; HYPOXIA; INSOMNIA; MAJOR DEPRESSION; METABOLIC SYNDROME X; MORTALITY; MUSCLE TONE; OBESITY; OXYGEN SATURATION; OXYGENATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOMOTOR RETARDATION; PSYCHOSIS; PULSE OXIMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SLEEP APNEA SYNDROME; SLEEP QUALITY; SYSTEMATIC REVIEW;

EID: 80052883928     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136-143.
2. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8):e1000132.
3. Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and longterm care of obstructive sleep apneain adults. J Clin Sleep Med.2009;5(3):263-276.
4. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008; 31(8):1079-1085.
5. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep.2008;31(8):1071-1078.
6. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-1111.
7. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4):352-360.
8. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apneahypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010;182(2):269-277.
9. George CF. Sleep apnea, alertness, and motor vehicle crashes. Am J Respir Crit Care Med. 2007;176(10):954-956.
10. Mickelson SA. Preoperative and postoperative management of obstructive sleep apnea patients. Otolaryngol Clin North Am. 2007;40(4):877-889.
11. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291(16):2013-2016.
12. Valham F, Mooe T, Rabben T, et al. Increased risk of stroke in patient swith coronary artery disease and sleep apnea: a 10-year follow-up. Circulation. 2008;118(9):955-960.
13. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034-2041.
14. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
15. Nguyen AT, Baltzan MA, Small D, et al. Clinical reproducibility of the Epworth Sleepiness Scale. J Clin Sleep Med. 2006;15(2)2:170-174.
16. American Academy of Sleep Medicine. International Classification of Sleep Disorders, Second Edition, Diagnostic and Coding Manual. Westchester, Illinois: American Academy of Sleep Medicine; 2005.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
18. Kryger, MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine, Fourth Edition. W.B. Saunders: Philadelphia, PA; 2005.
19. Sharafkhaneh A, Giray N, Richardson P, et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep. 2005;28(11):1405-1411.
20. Baran AS, Richert AC. Obstructive sleep apnea and depression. CNS Spectr. 2003;8:128-134.
21. Andrews JG, Oei TPS. The roles of depression and anxiety in the understanding and treatment of obstructive sleep apnea syndrome. Clin Psychol Rev. 2004;24:1031-1049.
22. El-Ad B, Lavie P. Effect of sleep apnea on cognition and mood. Int Rev Psychiatry. 2005;17:277-282.
23. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
24. Gough HG. Diagnostic patterns on the Minnesota multiphasic personality inventory. J Clin Psychol. 1946;2:23-37.
25. Weissman MM, Sholomskas D, Pottenger M, et al. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;106(3):203-214.
26. Chandarana PC, Eals M, Steingart AB, et al. The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis. Can J Psychiatry. 1987;32(5):356-361.
27. Lorr M, McNair DM, Droppleman LF. Profile of Mood States™ (POMS). MHS Psychological Assessments and Services. Updated 2004. http://www.mhs.com/product.aspx?gr=cli&prod=poms&id=overview. Access August 31, 2011.
28. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
29. Guilleminault C, Eldridge FL, Tilkian A, et al. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med. 1977;137:296-300.
30. Reynolds CF, Kupfer DJ, McEachran AB, et al. Depressivepsychopathology in male sleep apneics. J Clin Psychiatry. 1984;45:287-290.
31. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry.1989;50:348-351.
32. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry.2003;64:1195-200.
33. Schwartz DJ, Kohler WC, Karatinos G. Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest. 2005;128:1304-1309.
34. Yamamoto H, Akashiba T, Koska N, et al. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnea. Respir Med. 2000;94:87-90.
35. Phillips BA, Berry DT, Lipke-Molby TC. Sleep-disordered breathing in healthy, aged persons: fifth and final year follow-up. Chest.1996;110:654-658.
36. Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome:effects of gender and respiratory disturbance index. Chest. 1998;114:697-703.
37. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bull.1973;9(1):13-28.
38. Lee C, Moton CC. Structural genomic variation and personalized medicine. N Engl J Med.2008;358:740-741.
39. Olson EJ, More WR, Morgenthaler TI, et al. Obstructive sleep apneahypopnea syndrome. Mayo Clin Proc. 2003;78(12):1545-1552.
40. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med.2004;66:305-315.
41. Ramasubbu R. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses. 2002;59:537-551.
42. Enright PL, Newman AB, Wahl PW, et al. Prevalence and correlates of snoringand observedapneas in 5,201 older adults. Sleep.1996;19:531-538.
43. Smith R, Ronald J, Delaive K, et al. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest. 2002;121:164-72.
44. Aloia MS, Arnedt JT, Smith L, et al. Examining the construct of depression in obstructive sleep apnea syndrome. Sleep Med. 2005;6:115-121.
45. Farney RJ, Lugo A, Jensen RL, et al. Simultaneous use of antidepressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome. Chest. 2004;125:1279-1285.
46. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleeprelated breathing disorder and depression. Arch Intern Med. 2006;166:1709-1715.
47. Kripke DF, Ancoli-Israel S, Klauber MR, et al. Prevalence of sleep disordered breathing in ages 40-64 years: a populationbased survey. Sleep. 1997;20:65-76.
48. Sforza E, de Saint Hilaire Z, Pelissolo A, et al. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002;3:139-145.46.
49. Gami AS, Somers VK. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J. 2004;25:709-711.
50. Cohen-Zion M, Stepnowsky C, Marler, et al. Changes in cognitive function associated with sleep disordered breathing in olderpeople. J Am Geriat Soc.2001;49(12):1622-1627.
51. Stepanski E, Lamphere J Badia P, et al. Sleep fragmentation and daytime sleepiness. Sleep. 1984;7(1):18-26.
52. Ishman S, Carey RM, Meltel T. Depression, sleepiness and disease severity in patients with obstructive sleep apnea. Laryngoscope. 2010;120(11):2331-2335.
53. Bardwell WA, Berry CC, Ancoli- Israel S, Dimsdale JE. Psychological correlates of sleep apnea. J Psychosomatic Res.1999;47(6):583-596.
54. Bardwell WA, Norma D, Ancoli- Israel S, et al. Effects of 2 week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med. 2007;5(1):21-38.
55. Gozal D, Daniel JM, Doharrich GP. Behavioral and anatomic correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci. 2001;21(7):2442-2450.
56. Cross RL, Kumar R, Macey PM, et al. Neural alterations and depressive symptoms in OSA patients. Sleep. 2008;31(8):1103-1109.
57. Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med.2006;2(4):461-471.
58. Canessa N, Castronovo V, Cappa S, et al. Obstructive sleep apnea: brain structural changes and neurocognitive functions before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419-1426.
59. Muñoz A, Mayoralas LR, Barbé F, et al. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J. 2000;15(4):676-681.
60. Jans LA, Riedel WJ, Markus CR, Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry. 2007;12(6):522-543.
61. Khawaja IS, Gajwani P, Westermeyer J, Feinstein R. Depression and coronary artery disease: association, mechanism and treatment. Psychiatry (Edgmont). 2009;6(1):38-51.
62. Euteneuer F, Schwarz MJ, Hennings A, et al. Depression, cytokines and experimental pain: evidence for sexrelated association patterns. J Affect Disord. 2010 Dec 15. [Epub ahead of print]
63. Miles LE, Dement WC. Sleep and aging. Sleep. 1980;3(2):1-220.
64. Guilleminault C. Benzodiazepines, breathing, and sleep. Am J Med. 1990;88(3A):25S-28S.
65. Habukawa M, Uchimura N, Kakuma T, et al. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: contribution of daytime sleepiness to residual depressive symptoms. Sleep Med.2010;11(6):552-557. Epub 2010 May 21.
66. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.67.
67. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343(8897):572-575.
68. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997;52(2):114-119.
69. Means MK, Lichstein KL, Edinger JD, et al Changes in depressive symptoms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath. 2003;7(1):31-42.
70. McMahon JP, Foresman BH, Chisholm RC. The influence of CPAP on the neurobehavioral performance of patients with obstructive sleep apnea hypopnea syndrome: a systematic review. WMJ. 2003;102(1):36-43.
71. YYu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res. 1999;33(5):427-432.
72. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2001;163(4):911-917.
73. Borak J, CieÊlicki JK, Koziej M, et al. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res. 1996;5(2):123-127.